Patent 7709645 was granted and assigned to SGX Pharmaceuticals on May, 2010 by the United States Patent and Trademark Office.
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.